Significant Gross Margin Expansion and Profitability
Reported gross profit of $36.2M, up 10.4% year-over-year; gross margin improved to 29.7% from 24.6%, a 510 basis point expansion. Operating profit grew 115% to $5.0M (from $2.3M prior-year) and net income was $3.5M ($0.26 diluted EPS) versus $1.8M ($0.13) a year ago.
Margin Drivers and Tariff Mitigation
Margin expansion driven by implementation of a foreign trade zone, capitalizing on the Supreme Court IEPA ruling, diversified sourcing, and selective price increases. Management identified a one-time 190 basis point benefit tied to sell-through of inventory priced for eliminated IEPA tariffs, plus 320 basis points from price timing and higher-margin mix.
Strong Product Innovation and Retail Wins
Launched three innovative blender kitchen systems and a redesigned Durathon iron (positive market reception); expanding into garment steamers and two single-serve coffee platforms launching in H2. Secured expanded placements with a leading department store (fall), shelf space at two top wholesale membership clubs, and increased penetration with a leading mass retailer.
LOTUS Brand Momentum in Premium Segment
LOTUS Professional delivered strong double-digit sell-through in 2025; rollout to other retailers in 2026 underway and LOTUS Signature planned for holiday launch. Management highlights a large premium market (~$9B U.S. appliance market, ~50% premium) and sees substantial runway from current ~1% share.
Commercial Business Traction
Commercial offerings gaining adoption: Summit Edge blender remains core, Eclipse blender will be added to a leading national coffee chain, spindle maker placement for a fast-food chain in Central America, and Sunkist commercial juicers/sectionizers showing accelerating demand from restaurants, hospitality chains, and schools.
Health Business Acceleration
Health division achieved its third consecutive quarter of profitable growth and is on track to increase sales by 50% in 2026. Added a new injectable drug to the SmartSharp Spin platform and plans to pilot a pill management platform in Q3 targeting oncology and mental health initially.
Digital and Marketing Enhancements
Increased investment in digital, social media, influencer marketing, and discoverability initiatives; average consumer ratings above four stars across brands. Company selected a new advertising agency to drive digital strategy starting in H2.
Share Repurchases and Dividend Actions
Returned capital via repurchase of ~55,000 shares for approximately $900K and paid $1.6M in dividends during the quarter.